Ipca Laboratories Limited (IPCALAB.NS) NSE

1,517.00

+9.2(+0.61%)

Updated at January 14 03:30PM

Currency In INR

Valuation

Market Cap352.86B
Enterprise Value364.82B
P/E Ratio46.26
PEG Ratio6.79
Price/Sales Ratio4.11
Price/Book Ratio5.18
Enterprise/Revenue4.23
Enterprise/EBITDA22.46

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.33

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue89.41B
Revenue/Share368.97
Gross Profit58.6B
EBITDA16.67B
Net Income7.38B
Diluted EPS29.08

Balance Sheet

Total Cash12.83B
Total Cash/Share50.58
Total Debt12.79B
Total Debt/Equity0.17
Current Ratio2.46
Book Value Per Share349.52

Price History

52-Week Change-4.48
52-Week High1,595
52-Week Low1,168.2
Moving Average 50 Days1,426.99
Moving Average 200 Days1,393.92

Statistics

Average Volume288,528
Shares Outstanding253.7M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate4
Trailing Annual Dividend Yield0.26
Payout Ratio0
Last Split Factor2:1
Last Split DateJanuary 10, 2022